Sun Wenlong, Jia Jinghan, Liu Guangpeng, Liang Shufei, Huang Yuhong, Xin Meiling, Chang Zukang, Liu Xingxing, Ma Chao, Song Xinhua, He Fatao, Song Yuanda, Wu Maoyu
All China Federation of Supply and Marketing Cooperatives Jinan Fruit Research Institute, Jinan 250014, China.
School of Life Sciences and Medicine, Shandong University of Technology, Zibo 255000, China.
J Agric Food Chem. 2025 Mar 19;73(11):6632-6645. doi: 10.1021/acs.jafc.4c07078. Epub 2025 Mar 5.
Nonalcoholic fatty liver disease (NAFLD) ranks among the most prevalent chronic liver diseases worldwide, yet effective treatments remain scarce. Old stalks of L. are rich in polysaccharides. The anti-NAFLD mechanism of polysaccharides from old stalks of (AP) requires further study. Here, we studied the effects of AP on NAFLD mice and its impact on the gut microbiota. AP intervention reduces blood lipids and liver lipids and reduces liver injury and inflammation in mice with NAFLD. Moreover, AP intervention changed gut microbiota composition and increased the abundances of butyric acid-producing bacteria, thereby increasing plasma concentration of butyric acid. Furthermore, AP intervention regulated the AMPK/SREBPs signaling pathway, thereby affecting hepatic lipid synthesis. Additionally, AP intervention improved gut barrier function and reduced plasma LPS levels, which subsequently inhibited the LPS/TLR4/NF-κB signaling pathway, thereby alleviating inflammation in NAFLD model mice. Importantly, fecal microbiota transplant (FMT) outcomes demonstrated that AP-induced changes in the gut microbiota impact the AMPK/SREBPs and LPS/TLR4/NF-κB pathways. These data suggest that AP intervention ameliorates NAFLD by regulating the gut microbiota. These research provides a scientific foundation for the use of the stalks of in the treatment of NAFLD.
非酒精性脂肪性肝病(NAFLD)是全球最常见的慢性肝病之一,但有效的治疗方法仍然稀缺。[植物名称]的老茎富含多糖。[植物名称]老茎多糖(AP)的抗NAFLD机制需要进一步研究。在此,我们研究了AP对NAFLD小鼠的影响及其对肠道微生物群的影响。AP干预可降低NAFLD小鼠的血脂和肝脂,并减轻肝损伤和炎症。此外,AP干预改变了肠道微生物群的组成,增加了产丁酸细菌的丰度,从而提高了血浆丁酸浓度。此外,AP干预调节了AMPK/SREBPs信号通路,从而影响肝脏脂质合成。另外,AP干预改善了肠道屏障功能,降低了血浆LPS水平,随后抑制了LPS/TLR4/NF-κB信号通路,从而减轻了NAFLD模型小鼠的炎症。重要的是,粪便微生物群移植(FMT)结果表明,AP诱导的肠道微生物群变化影响了AMPK/SREBPs和LPS/TLR4/NF-κB通路。这些数据表明,AP干预通过调节肠道微生物群改善了NAFLD。这些研究为[植物名称]的茎在治疗NAFLD中的应用提供了科学依据。